v3.22.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Revenue $ 1,641 $ 1,450
Cost of revenue 1,321 1,068
Gross profit 320 382
Operating expenses:    
Research and development 2,140 1,930
Selling, general and administrative 3,653 3,581
Total operating expenses 5,793 5,511
Loss from operations (5,473) (5,129)
Modification of warrants 0 (287)
Interest expense, net (270) (234)
Other expense, net (21) (65)
Net loss from consolidated companies (5,764) (5,715)
Loss from investment in unconsolidated limited liability company (122) (76)
Comprehensive and net loss (5,886) (5,791)
Series B convertible preferred stock dividends (1,266) (1,119)
Net loss attributable to common stockholders $ (7,152) $ (6,910)
Net loss per share of common stock:    
Basic and diluted (in dollars per share) $ (0.67) $ (0.80)
Weighted average shares used in computing net loss per common share:    
Basic and diluted (in shares) 10,620,076 8,636,120

Source